Acadian Asset Management LLC Abbott Laboratories Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

A detailed history of Acadian Asset Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Acadian Asset Management LLC holds 756,208 shares of ABT stock, worth $87 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

756,208

Previous 319,169 136.93%

Holding current value

$87 Million

Previous $33.2 Million 159.98%

% of portfolio

0.27%

Previous 0.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $43.7 Million - $51.6 Million	437,039 Added 136.93%	756,208 $86.2 Million
Q2 2024 Aug 06, 2024	BUY	$100.73 - $112.44 $26.9 Million - $30 Million	266,899 Added 510.62%	319,169 $33.2 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $1.79 Million - $1.97 Million	16,300 Added 45.32%	52,270 $5.94 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $920,208 - $1.13 Million	10,203 Added 39.6%	35,970 $3.96 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $974,023 - $1.17 Million	-10,196 Reduced 28.35%	25,767 $2.49 Million
Q2 2023 Aug 07, 2023	SELL	$100.78 - $112.29 $4.73 Million - $5.28 Million	-46,977 Reduced 56.64%	35,963 $3.92 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $996,398 - $1.17 Million	-10,287 Reduced 11.03%	82,940 $8.39 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $3.82 Million - $4.48 Million	-40,184 Reduced 30.12%	93,227 $10.2 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $23.3 Million - $27 Million	-241,033 Reduced 64.37%	133,411 $12.9 Million
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $6.28 Million - $7.59 Million	-61,526 Reduced 14.11%	374,444 $40.7 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $9.04 Million - $11 Million	79,265 Added 22.22%	435,970 $51.6 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $9.28 Million - $11.4 Million	80,293 Added 29.05%	356,705 $50.2 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $26.2 Million - $29 Million	-224,981 Reduced 44.87%	276,412 $32.6 Million
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $2.94 Million - $3.46 Million	-27,797 Reduced 5.25%	501,393 $58.1 Million
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $43.8 Million - $51.6 Million	402,723 Added 318.44%	529,190 $63.4 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $4.34 Million - $4.72 Million	41,295 Added 48.48%	126,467 $13.8 Million
Q3 2020 Nov 09, 2020	BUY	$91.64 - $111.29 $487,983 - $592,619	5,325 Added 6.67%	85,172 $9.27 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $6.11 Million - $7.83 Million	79,847 New	79,847 $7.3 Million
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $2.76 Million - $3.07 Million	-35,102 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$81.84 - $88.74 $2.87 Million - $3.11 Million	35,102 New	35,102 $2.94 Million
Q2 2019 Aug 08, 2019	SELL	$72.88 - $85.0 $9.18 Million - $10.7 Million	-125,985 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$66.22 - $80.06 $3.33 Million - $4.03 Million	-50,357 Reduced 28.56%	125,985 $10.1 Million
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $4.44 Million - $5.02 Million	67,649 Added 62.24%	176,342 $12.8 Million
Q3 2018 Oct 30, 2018	BUY	$60.81 - $73.36 $5.52 Million - $6.66 Million	90,754 Added 505.9%	108,693 $7.97 Million
Q2 2018 Jul 24, 2018	BUY	$57.57 - $63.54 $645,129 - $712,029	11,206 Added 166.43%	17,939 $1.1 Million
Q1 2018 Apr 12, 2018	BUY	$56.27 - $63.62 $181,414 - $205,110	3,224 Added 91.88%	6,733 $403,000
Q3 2017 Oct 13, 2017	BUY	$48.06 - $53.64 $168,642 - $188,222	3,509	3,509 $187,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Abbott Laboratories Transaction History